Adagene Inc - ADR
ADAG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$111.43M
Close$
$1.68
31.9% downside
Current Fair Value
31.9% downsideOvervalued by 31.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $111.43 Million |
|---|---|
| Enterprise Value | $-8,213,670.00 |
| Earnings per Share | $-0.46 |
| Beta | 0.54 |
| Outstanding Shares | 45,295,212 |
Return
| Return on Equity | -55.64% |
|---|---|
| Return on Assets | -44.16% |
| Return on Invested Capital | -55.03% |
Valuation & Multiples
| P/E Ratio | -5.32 |
|---|---|
| PEG | -24.76 |
| Price to Sales | - |
| Price to Book Ratio | 1.23 |
| Enterprise Value to Revenue | -2.67 |
| Enterprise Value to EBIT | 0.43 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.33 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.22
Consensus analyst estimateRevenue Estimate
$17.50 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
$-0.21
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.07%▼ 42.45% |
|---|---|
| Total Invested | $102,259▼ 99.87% |
| Investors Holding | 2▼ 34.00% |
About Adagene Inc
2,020 employees
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial int...